170263 ⎘
Assays involving biological materials from specific organisms or of a specific nature from viruses; RNA viruses Coronaviridae, e.g. avian infectious bronchitis virus
Sub-classes:Coronavirus Assays, Diagnostic Methods, Treatment Methods, and Compositions Related Thereto
#2METHODS, COMPOSITIONS, AND SYSTEMS FOR DETECTING CORONAVIRUS NEUTRALIZING ANTIBODIES
#3COLORIMETRIC DETECTION OF A VIRAL INFECTION
#4EVOLUTION OF FLUOROGENIC SENSORS
#5BIOMOLECULAR DETECTION METHOD AND DETECTION SYSTEM THEREOF
#6METHODS FOR MONITORING IMMUNE STATUS OF A POPULATION
#7AMPLIFYING BIOMOLECULAR SENSING THROUGH ACOUSTICALLY ENHANCED REACTIONS
#8NANOBODY-FUNCTIONALIZED BIOLOGICAL NANOPORES AND MEANS AND METHODS RELATED THERETO
#9REAL-TIME, POINT OF CARE DIAGNOSTIC AND METHOD OF USE THEREOF
#10ENGINEERED PHAGE AND KIT FOR CAPTURING SARS-COV-2 AND METHOD FOR DETECTING SARS-COV-2 VIRUS BY MEANS OF SAID PHAGE OR KIT
#11IMMUNOGENIC COMPOSITIONS AND USE THEREOF
#12ULTRA-SENSITIVE ANALYTE DETECTION AND QUANTIFICATION USING CATCH AND RELEASE WITH PROXIMITY DETECTION
#13CARTRIDGE-BASED AUTOMATED RAPID TEST ANALYZER
#14METHOD AND REAGENTS FOR ULTRASENSITIVE IMMUNOASSAY
#15BIOMARKERS FOR CHRONIC FATIGUE SYNDROME AND LONG COVID AND USES THEREOF
#16AIR-SEGMENTED INJECTION OF FLUIDS IN A FLOW CELL FOR SPR ANALYSIS
#17PROTEIN BIOSENSOR SYSTEMS TO DETECT MUTATED COVID FROM SPUTUM AND BLOOD
#18IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
#19VIRAL SEROLOGY ASSAYS
#20HUMAN BROADLY NEUTRALIZING ANTIBODIES AGAINST BETACORONAVIRUSES
#21METHOD FOR PRETREATMENT OF SPECIMEN FOR IMMUNOCHROMATOGRAPHIC TEST
#22REAGENT, KIT, AND METHOD FOR DETECTING SUBSTANCE TO BE MEASURED
#23REAGENT FOR DETECTING SARS-RELATED CORONAVIRUS
#24METHODS AND DEVICES FOR DETECTING A PATHOGEN AND ITS MOLECULAR COMPONENTS
#25Method and System for Exposing Hidden or Masked Antigenic Sites of Viral Specimens Present in Biosamples Using a Home-Based COVID-19 Rapid Lateral Flow Immunoassay Test
#26NEUTRALIZATION ANTIBODY ASSAY METHOD
#27COVID-19 Mucosal Antibody Assay
#28ANTI-SARS-COV2 SPIKE (S) ANTIBODIES AND USES THEREOF
#29NASAL CAVITY SAMPLING METHODS AND APPARATUS
#30RNA-Coliphage Q-Beta Biosensors
#31VIRAL STRAIN SEROLOGY ASSAYS
#32SARS-COV-2 POLYPEPTIDE, ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF
#33NOVEL COV-2 ANTIBODIES
#34COMPOSITION, METHODS AND USES
#35SYSTEMS AND METHODS FOR AIRBORNE ENVIRONMENTAL DETECTION AND SURVEILLANCE OF PATHOGENS WITH ELECTROCHEMICAL ANALYSIS
#36QUARTZ CRYSTAL MICROBALANCE DEVICE AND BIOASSAY
#37ANTIGENIC POLYPEPTIDE AND USE THEREOF
#38CHIMERIC ANTI-SARS-COV2 NUCLEOPROTEIN ANTIBODIES
#39IMMUNOASSAY FOR DETECTING BIOLOGICALLY ACTIVE PROTEINS
#40SARBECOVIRUS SPIKE S2 SUBUNIT BINDERS
#41METHODS AND SYSTEMS OF PREDICTING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C)
#42HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 1 (SARS-CoV-1)
#43A MOLECULAR SENSOR AND METHODS FOR USE
#44DUAL-SYSTEM METHOD FOR ASSESSING TRANSMISSIBILITY AND DISEASE SEVERITY OF RESPIRATORY VIRUSES
#45SARS-CoV-2 Virus-Like Particles
#46RNA SEPARATION AND RELATED TECHNIQUES FOR DETERMINING VIRUSES SUCH AS CORONAVIRUSES
#47TEST METHOD, TEST REAGENT, AND TEST KIT
#48HIGH SENSITIVITY DNA LINKED IMMUNOSORBENT SIGNAL AMPLIFICATION ASSAY (DLISA) FOR DETECTION OF INFECTIOUS SARS-COV-2 VIRUS AND VARIANTS
#49SYSTEMS AND PROCESSES TO SCREEN FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) OF 2019 (COVID-19)
#50SENSITIZER FOR IMMUNOCHROMATOGRAPHIC ASSAYS, AND ASSAY
#51SARS-COV-2 N PROTEIN-SPECIFIC SINGLE-CHAIN ANTIBODY, AND FUSION PROTEIN AND USE THEREOF
#52Camelid Antibodies for Use in Therapy and Diagnosis
#53ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME
#54METHODS AND REAGENTS OF IMMUNOLOGICALLY DETECTING SARS-CoV-2
#55BLOOD BIOMARKERS IN LONG-COVID-19
#56ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF II
#57ANTIBODY COMPOSITIONS AND OPTIMIZATION METHODS
#58METHODS AND KITS FOR VIRUS DETECTION
#59GLYCOSAMINOGLYCAN ARTICLES AND METHODS RELATING THERETO
#60NEW METHOD TO DIAGNOSE INFLAMMATORY DISEASES
#61Coronavirus T Cell Epitopes, Megapools and Uses Thereof
#62METHODS AND USES OF CRISPR CASCADE REACTIONS FOR CRISPR DIAGNOSTICS
#63Novel Peptides and Vaccines Capable of Eliciting Protective Immunity Against SARS-CoV-2
#64Rolling Sensor Systems for Detecting Analytes and Diagnostic Methods Related Thereto
#65HIGH SENSITIVITY AND SELECTIVITY VERTICALLY-ORIENTED SILICON NANOWIRE ARRAY-BASED BIOELECTRONIC SENSOR PLATFORM
#66MODIFIED SPIKE PROTEINS AND USES THEREOF
#67Using Exhaled Breath Condensate, Aerosols and Gases for Detecting Biomarkers
#68METHOD OF PROTEASE DETECTION
#69Method for Rapid Capture, Detection and Analysis of Viruses on Surfaces
#70A METHOD AND SYSTEM FOR MEASURING A MODIFIED PROPERTY OF A SAMPLE COMPRISING MAGNETIC PARTICLES IN LIQUID SUSPENSION
#71RAPID, SINGLE-USE METHODS AND SYSTEMS FOR ELECTROCHEMICAL ANALYSIS OF PATHOGENS IN EXHALED BREATH
#72METHOD FOR DETECTING ANALYTE USING POLYNUCLEOTIDE
#73ANALYTICAL METHOD
#74Methods and Compositions For Measuring Serum Analyte Levels From Biological Matrices
#75RAPID DETECTION AND ANALYSIS OF BIOLOGICAL COMPONENTS USING SURFACE ENHANCED RAMAN SPECTROSCOPY
#76ATTENUATED SARS-COV-2
#77RECOMBINANT ANTIBODIES COMPRISING ANTI-HUMAN IMMUNOGLOBULIN G-INVERTASE FUSION PROTEINS AND METHODS OF USING THE SAME
#78DEVICE AND METHOD FOR PATHOGEN DETECTION
#79COMPOSITION FOR POC PCR
#80MACROSCOPIC LASER-INDUCED GRAPHENE
#81ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CONONAVIRUS SARS-COV-2
#82DETECTION AGENT, DETECTION SYSTEM AND METHOD THEREOF
#83HUMAN MONOCLONAL ANTIBODIES TARGETING THE S2 SUBUNIT OF THE SARS-COV-2 SPIKE PROTEIN
#84PEPTIDE
#85COMPOSITIONS, KITS, AND METHODS FOR DUPLEX IMMUNOASSAY FOR ANTI-SARS-COV-2 ANTIBODIES
#86DIAGNOSTIC ASSAY METHODS USING ASSAY DEVICE HAVING MICROREACTOR
#87Using Exhaled Breath Condensate for Testing for a Biomarker of COVID-19
#88COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#89METHODS, DEVICES, AND RELATED ASPECTS FOR DETECTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2
#90DIAGNOSTIC ASSAY DEVICE HAVING MICROREACTOR
#91ALVEOLAR ORGANOIDS, METHODS OF MAKING AND USES THEREOF
#92C3D4 Human Cell Model for MERS and SARS-C0V-2 Infection
#93MULTIPLEXED DIAGNOSTIC ASSAY DEVICE
#94THERMALLY RESPONSIVE PARTITIONS FOR DEVICES AND SYSTEMS AND METHODS OF USING SAME
#95METHOD FOR DETECTING BIOLOGICAL OBJECTS BY MEANS OF SURFACE PLASMON RESONANCE IMAGING
#96ANTI-SARS-CoV-2 SPIKE (S) ANTIBODIES AND THEIR USE IN TREATING COVID-19
#97SARS-CoV-2 BINDING PROTEINS AND METHODS OF USE THEREOF
#98APTAMERS FOR DETECTING VARIANTS OF A TARGET ANALYTE, METHODS OF MAKING AND USES THEREOF
#99METHOD FOR EVALUATING SEVERITY RISK OF CORONAVIRUS INFECTIOUS DISEASE, AND KIT FOR EVALUATING SEVERITY RISK OF CORONAVIRUS INFECTION DISEASE
#100METHOD FOR DETECTING ANTI-SARS-COV-2 SPIKE (S) IMMUNOGLOBULINS
#101LATERAL FLOW ASSAY BY USING CARBOXYL LATEX BEADS AND BIOTIN-POLYSTREPTAVIDIN FOR THE DETECTION OF COVID-19 INFECTION AND DIAGNOSTIC KIT USING THE LATERAL FLOW ASSAY
#102PRODUCTION OF ELISA REAGENTS AND VACCINES BY 'ONE PROCESS'
#103METHODS OF DETECTING VIRAL OR BACTERIAL INFECTIONS
#104THERMODYNAMIC PREDICTION
#105DIAGNOSTIC LIPID BIOMARKERS FOR COVID-19 AND METHODS FOR USE THEREOF
#106SINGLE PARTICLE ANALYSIS METHOD FOR VIRAL NUCLEIC ACID VECTOR
#107Graphene-Based Sensor for Detecting SARS-COV-2 Virus in a Biological Sample
#108MONITORING COVID-19 PROGRESSION AND TREATMENT
#109APPARATUS AND METHOD FOR FLUID ANALYTE DETECTION USING RING RESONATOR BASED SPECTROSCOPY
#110DEORPHANIZING ODORS USING SINGLE CELL SEQUENCING
#111Physiological Metrics as Candidate Predictors of Antibody Response Following Vaccination Against Covid-19
#112BIOASSAYS TO MEASURE THE SYNERGISTIC ANTIBODY-DEPENDENT ENHANCEMENT (ADE) EFFECT OF SARS-CoV-2 NEUTRALIZING ANTIBODIES
#113BRET-BASED, DUAL PROTEASE BIOSENSOR
#114MULTI-TARGETED, MODULAR VIRUS SENSING PLATFORM
#115PREDICTING COVID-19 ANTIBODIES AMONG SURVIVORS WITH DEEP RNA SEQUENCING
#116DIRECTLY FUNCTIONALIZED ELECTROCHMICAL TRANSISTEORS, AND CONVECTION DRIVEN ULTRA-RAPID DETECTION OF BIOMARKERS USING TRANSISTORS
#117POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#118FLUID CONTROL IN MICROFLUIDIC DEVICES
#119COMPOSITIONS AND METHODS RELATED TO A DUAL-AFFINITY RATIOMETRIC QUENCHING BIOASSAY FOR DETECTING GLYCOPROTEINS
#120BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF
#121CALIBRATION SAMPLE FOR DETECTING ANTI-BARTONELLA HENSELAE ANTIBODIES
#122SARS-COV-2 POLYPEPTIDES AND USES THEREOF
#123IMMUNOCHROMATOGRAPHY TEST STRIP AND IMMUNOCHROMATOGRAPHY KIT, IMMUNOASSAY METHOD USING SAME, AND SAMPLE FILTRATION METHOD
#124COMPOSTIONS
#125QUANTIFICATION OF AIRBORNE SARS-COV-2 USING A PAPER MICROFLUIDIC CHIP
#126A RECOMBINANT CONSTRUCT FOR SCREENING DRUGS AGAINST SARS-COV-2 SPIKE PROTEIN
#127NUCLEIC ACID-BASED MULTIPLEXED LATERAL FLOW ASSAY FOR DISEASE DETECTION
#128SARS-CORONAVIRUS 2 NEUTRALIZING ANTIBODY
#129IDENTIFICATION AND USES OF PEPTIDE SEQUENCES OF SARS-COV-2 T CELL AND B CELL EPITOPES
#130Detection of SARS-CoV-2
#131CORONAVIRUS FUSION PROTEIN
#132ELECTRON-TUNNELING OR HOPPING BASED AERIAL VIRAL DETECTOR
#133DEVICE AND METHOD FOR PATHOGEN DETECTION
#134ELECTROCHEMICAL BIOMOLECULE-FUNCTIONALIZED SENSOR DEVICE AND METHODS OF MAKING AND USING THE SAME
#135SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN
#136Quantitation of chemical, biological and biochemical analytes on a flow assay using a smartphone
#137CHIP-BASED CARTRIDGE FOR BIOLOGICAL DETECTION AND USES THEREOF
#138THERMALLY RESPONSIVE PARTITIONS FOR DEVICES AND SYSTEMS AND METHODS OF USING SAME
#139SARS-COV-2 VACCINES
#140BIOLOGICS DETECTION DEVICE
#141SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES
#142DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOF
#143MULTIPLEXED ELECTRONIC IMMUNOASSAY USING ENZYMATICALL AMPLIFIED METALLIZATION ON NANOSTRUCTURED SURFACES
#144METHODS AND DEVICES FOR DETECTING A PATHOGEN AND ITS MOLECULAR COMPONENTS
#145COMPOSITIONS AND METHODS FOR DETERMINING HUMORAL IMMUNE RESPONSES AGAINST SEASONAL CORONAVIRUSES AND PREDICTING EFFICIENCY OF SARS-COV-2 SPIKE TARGETING, COVID-19 DISEASE SEVERITY, AND PROVIDING INTERVENTIONS
#146ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF IN THE MEDICAL FIELD
#147COMPOSITIONS FOR PREVENTING AND/OR REDUCING VIRAL INFECTION
#148METHOD OF EVALUATING PROGRESSION OF AN INFECTIOUS DISEASE AND/OR INFLAMMATORY DISEASE
#149NANOSENSOR FOR DETECTING SARS-CoV-2 SPECIFIC ANTIBODIES
#150APTAMER-BASED ELECTROCHEMICAL VIRUS DETECTOR AND METHODS THEREOF
#151SYSTEMS AND METHODS FOR PATHOGEN DETECTION
#152LIVE YEAST BIOSENSORS AND METHODS OF USE THEREOF
#153PLATFORMS FOR ANTIBODY SUBPOPULATION DETECTION
#154LUMINESCENT BASED ANTIGEN ASSAY
#155COVID-19 IMMUNE RESPONSE ASSAY METHOD
#156FLUID SAMPLE CONCENTRATOR
#157MXENE-GRAPHENE FIELD EFFECT TRANSISTOR VIRUS SENSOR
#158ANALYSIS METHOD
#159Compositions and methods for detecting SARS-CoV-2 spike protein
#160METHOD AND SYSTEM FOR MEASURING CELL-MEDIATED IMMUNITY TO ADENO-ASSOCIATED-VIRUS INFECTION
#161System and method for transistor pathogen detector
#162METHODS AND REAGENTS FOR THE DETECTION OF ANALYTES
#163ULTRASENSITIVE RAPID ANTIGEN DETECTION KIT AND DETECTION METHOD THEREOF
#164COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS
#165METHOD FOR PRODUCING A BIOMODIFIED SENSOR FOR DETECTING AND MEASURING PATHOGENS
#166Rapid And Ultrasensitive Analyte Detection For Screening In Community Settings
#167SARS-COV-2 NEUTRALIZING ANTIBODIES AND USES THEREOF
#168CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS
#169CHROMATOGRAPHY DEVELOPING SOLUTION, KIT, CHROMATOGRAPH DEVICE, AND METHOD FOR DETECTING TEST SUBSTANCE
#170ASSAY KIT AND CHROMATOGRAPHIC METHOD
#171BIOSENSOR AND VIRUSOMETER FOR THE DETECTION OF PATHOGENS IN AIR AND LIQUID SAMPLES
#172NANOWIRE-BASED IMMUNOFLUORESCENCE KIT FOR DETECTING SARS CORONAVIRUS 2 ANTIBODY, AND USE THEREOF
#173DEVELOPMENT OF NOVEL APTAMER-BASED BIOSENSOR FOR DETECTION OF SARS-COV-2 PROTEIN IN NASOPHARYNGEAL SWABS OF COVID-19 PATIENTS
#174ONE-POT PATHOGEN DETECTION SYSTEM AND METHOD FOR REAL-TIME LATERAL FLOW ASSAY
#175Detecting SARS-CoV-2 and Other Infective Agents
#176Method For Concentration And Avidity Detection Of Antibodies Against Immune System Related Diseases Measured With Evanescent Field Based Biosensors Using A Continuous Gradient Of Ligand Densities
#177METHOD TO IDENTIFY INDIVIDUALS WITH T CELL IMMUNITY TO SPECIFIC INFECTIOUS AGENTS
#178REVERSE GENETICS-BASED COMPOSITIONS OF ATTENUATED RECOMBINANT SARS-COV-2
#179SAMPLE LYSIS REAGENT COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF
#180SYSTEM AND METHODS FOR DETECTION OF PATHOGENIC VIRUSES
#181Methods, Assays and Systems for Detection of a Target Analyte
#182ANTIBODIES TO SARS-COV-2
#183INFORMATION PROVISION METHOD FOR EXAMINING ACTIVE IMMUNITY BY USING PRODUCTION OF NEUTRALIZING ANTIBODIES AND INTERFERON GAMMA
#184ASSAY FOR SARS-CoV-2 INFECTION OF VULNERABLE HUMAN CELLS
#185HIGH-THROUGHPUT SEROTYPING AND ANTIBODY PROFILING ASSAYS
#186CROSS-NEUTRALIZING SARS-COV2 ANTIBODIES
#187CROSS-REACTIVE ANTIBODIES RECOGNIZING THE CORONAVIRUS SPIKE S2 DOMAIN
#188METHODS AND COMPOSITIONS BASED ON LONGITUDINAL STUDIES
#189ANTIBODY AGAINST NUCLEOCAPSID PROTEIN OF SARS-COV-2
#190RNA POLYMERASE ASSAY
#191ANTIBODY CAPABLE OF BINDING SPECIFICALLY TO NUCLEOCAPSID PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 OR FRAGMENT THEREOF, AND USE OF SAID ANTIBODY OR SAID FRAGMENT
#192VIRAL PROTEIN SPECIFIC APTAMERS AND METHODS OF USE IN DIAGNOSTICS, THERAPEUTIC PURPOSES
#193ANTIBODY AGAINST CORONAVIRUS
#194NANOBODY FUNCTIONALIZED ELECTROCHEMICAL TRANSISTORS AND METHODS OF MAKING AND USING THEREOF
#195AIRBORNE VIRUS SENSORS
#196MULTIPLEXED ANTIGEN-BASED DETECTION OF SARS-COV-2 AND OTHER DISEASES USING NANOMECHANICAL SENSORS
#197METHODS RELATED TO AN ALTERNATIVE CONFORMATION OF THE SARS-COV-2 SPIKE PROTEIN
#198SENSOR FOR DETECTING BIOMARKERS IN A FLUID SAMPLE AND METHODS OF USE
#199Method for Accumulating Microscopic Objects, and Method for Detecting Microscopic Objects Using Same
#200ANTIBODIES THAT BIND SARS-COV-2 SPIKE PROTEIN
#201ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM CR3022
#202SYSTEM, METHOD AND KITS FOR THE DETECTION OF BINDING AGENTS
#203BIOMARKERS FOR RESPIRATORY DISEASE AND METHODS USING THE SAME
#204METHOD FOR DETECTING ANTI-SARS-COV-2 ANTIBODY, CHIMERIC PROTEIN, POLYNUCLEOTIDE, EXPRESSION VECTOR, HOST CELL, METHOD FOR PRODUCING CHIMERIC PROTEIN, AND REAGENT
#205PAIRED-CELL PROFILING SYSTEMS FOR HIGH-THROUGHPUT SCREENING SYNCYTIUM FORMATION
#206SARS-COV-2 IMMUNOASSAY METHOD AND IMMUNOASSAY KIT
#207COVALENT APTAMERS
#208SARS-COV-2 RBD CONSTRUCTS
#209SYSTEMS AND METHODS FOR DETERMINING VIRUSES SUCH AS CORONAVIRUSES
#210High Sensitivity Analyte Network Detection Flow Assays And Related Methods
#211SARS-COV-2 IMMUNOASSAY METHOD AND IMMUNOASSAY KIT, AND MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT THEREOF
#212Methods to Identify Mutation Specific B Cells and Restore Therapeutic Antibody Efficacy Against Viral Variants
#213SARS-COV-2 SPIKE PROTEIN ANTIBODIES
#214Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2
#215SAFER VACCINES
#216CALIBRATION OF ELISA FOR CLINICAL ANTIBODY RESPONSE BY QUANTITATIVE MASS SPECTROMETRY
#217METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID
#218Methods for Monoclonal Antibody Generation
#219SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2
#220DEVICE FOR THE ELECTRONIC AND ELECTROCHEMICAL MEASUREMENT OF ANALYTE CONCENTRATIONS IN BIOLOGICAL SAMPLES
#221MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
#222RECOMBINANT SARS-COV-2 SPIKE PROTEIN AND USES THEREOF
#223METHODS FOR ISOLATING AND ANALYZING A TARGET ANALYTE ENCAPSULATED BY A SURFACE MARKER DISPLAYING AGENT
#224Method and System for Exposing Hidden or Masked Antigenic Sites of Viral Specimens Present in Biosamples Using a Home-Based COVID-19 Rapid Lateral Flow Immunoassay Test
#225DEVICE TO DETECT AIRBORNE PATHOGENS
#226CORONAVIRUS ANTIBODY
#227FLUOROGENIC SENSORS FOR DETECTING ANTIGENS
#228HUMAN ANTIBODY TARGETING COVID-19 VIRUS
#229COLOR: A LOW-COST OPTODIAGNOSTIC FOR SARS-COV-2
#230METHOD OF DETECTING DISEASE RELATED BIOMARKERS IN BODILY FLUID SAMPLE
#231SYSTEMS AND PROCESSES TO SCREEN FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) OF 2019 (COVID-19)
#232PEPTIDES AND THEIR USE IN DIAGNOSIS OF SARS-COV-2 INFECTION
#233A DEVICE AND ASSAYS FOR DETECTION OF PATHOGENS
#234IMPEDANCE-BASED NEUTRALIZING ANTIBODY DETECTION BIOSENSOR WITH APPLICATION TO SARS-CoV-2 INFECTION
#235SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE SAME
#236NOVEL COMPOUNDS PHOTO-CROSSLINKED BY VISIBLE LIGHT AND USES THEREOF
#237ALPHA-1-ANTITRYPSIN PHENOTYPE C DETECTION AND TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS ASSOCIATED WITH SAID PHENOTYPE
#238Method and Device for Inactivating New Coronavirus
#239Compositions, kits, and methods for anti-microbial serology assays using anti-human immunoglobulin antibody
#240LATERAL FLOW TEST METHODS
#241COPOLYMER, ANTIBODY-COPOLYMER CONJUGATE PREPARATION KIT, ANTIBODY-COPOLYMER CONJUGATE, METHOD FOR CONCENTRATING ANTIGEN, AND METHOD FOR DETECTING ANTIGEN
#242METHODS FOR DIAGNOSIS AND TREATMENT OF COVID-19
#243METHOD FOR DIRECT ANALYSIS OF FUNCTIONAL AVIDITY OF T CELLS
#244APTAMERS THAT SELECTIVELY BIND TO A SARS-COV-2 VIRUS NUCLEOCAPSID PROTEIN
#245MESOPOROUS NITRIC OXIDE-RELEASING SILICA PARTICLES, METHODS OF MAKING, AND USES THEREOF
#246METHODS AND COMPOSITIONS FOR IDENTIFYING VIRAL SEQUENCES
#247GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE
#248Neutralizing Anti-SARS-CoV-2 Antibodies and Methods of Use Thereof
#249Anti-coronavirus antibodies and methods of use
#250CALIBRATION OF ELISA FOR CLINICAL ANTIBODY RESPONSE BY QUANTITATIVE MASS SPECTROMETRY
#251METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID
#252SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2
#253CORONAVIRUS: EARLY DETECTION AND TREATMENT
#254ANTIVIRAL STRUCTURALLY-STABILIZED ACE2 HELIX 1 PEPTIDES AND USES THEREOF
#255ANTI-SARS-COV-2 ANTIBODY
#256Devices and Methods for Detection of Viruses from Exhaled Breath
#257POOLS OF MICROBIAL PROTEIN FRAGMENTS
#258ENGINEERING BACILLUS SUBTILIS AS A VERSATILE AND STABLE PLATFORM FOR PRODUCTION OF NANOBODIES
#259BIOSENSOR AND METHOD FOR DETERMINATION OF VIRUSES IN CORONAVIRUS FAMILY
#260IMMUNOLOGICAL TEST FOR THE DETECTION OF VIRAL INFECTIONS
#261PHOTONIC BIOSENSORS FOR MULTIPLEXED DIAGNOSTICS AND A METHOD OF USE
#262APTAMERS AND USE OF THE APTAMERS IN THE DIAGNOSIS AND TREATMENT OF A SARS-COV-2 INFECTION
#263METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE
#264Diagnostic assay methods using assay device having microreactor
#265DETECTION OF ACE2 IgM AUTOANTIBODIES AS MARKERS OF SEVERITY AND MECHANISM IN COVID19 PATIENTS
#266Diagnostic assay device having microreactor
#267DEVICE AND SYSTEM FOR THE DETECTION OF ENVIRONMENTAL CONTAMINANTS
#268SINGLE DOMAIN VHH ANTIBODIES AGAINST SARS-COV-2 VIRUS
#269ISOELECTRIC FOCUSING-BASED ENRICHMENT OF CHARGE VARIANT SPECIES
#270POLYPEPTIDES FOR DETECTION AND TREATMENT OF SARS-COV-2
#271ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME
#272HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY
#273MEANS AND METHODS OF PREVENTING, TREATING AND DETECTING INFECTIONS
#274METHODS AND SYSTEMS FOR DETECTION AND ANALYSIS OF ANGIOTENSIN BINDING ANTIBODIES
#275IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE
#276DETECTION OF AIRBORNE ANALYTES USING IMPRINTED MICELLES
#277ANTIBODY BINDING SPECIFICALLY TO SARS-COV-2 S PROTEIN OR ANTIGEN-BINDING FRAGMENT THEREOF, BISPECIFIC ANTIBODY, AND USES THEREOF
#278Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments
#279ENGINEERED ACE2 OLIGOMERS AND USES THEREOF
#280FLUORESCENCE ASSAY FOR IDENTIFYING PATHOGENS IN A SAMPLE, AND COMPUTER-IMPLEMENTED SYSTEMS FOR CARRYING OUT SUCH ASSAYS
#281METHODS, DEVICES AND SYSTEMS FOR DETECTION OF BIOMARKERS
#282BIOSENSOR FOR ELECTROCHEMICAL DETECTION OF E.G. MALARIA BIOMARKERS
#283COMPOSITIONS AND METHODS FOR DIAGNOSING SARS-COV-2 (COVID-19) AND FOR MONITORING SARS-COV-2-SPECIFIC IMMUNOLOGICAL MEMORY
#284CELL-FREE EXPRESSION OF ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND ANTIBODY DERIVATIVES
#285BIOSENSORS WITH ONE-DIMENSIONAL CONDUCTING POLYMER SYSTEMS
#286ASSAYS FOR RAPID DETECTION OF AIRBORNE VIRUSES INCLUDING INFLUENZA AND CORONAVIRUSES
#287CHIP FOR QUANTITATIVE DETECTION OF NEUTRALIZING ANTIBODY AND MANUFACTURING METHOD THEREOF
#288DEOXYRIBONUCLEIC ACID-BASED BIOSENSOR AND ASSOCIATED METHODS
#289Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2
#290Methods, Compositions, and Systems for Modulation of Coronavirus Infection
#291VIRAL DETECTION SYSTEMS AND USES THEREOF
#292Rapid Pathology or Cytology, Particularly Without Wash
#293DEVELOPMENT OF A NOVEL ELISA-BASED POINT-OF-CARE ANTIGEN TEST FOR SARS-COV-2
#294SYSTEM AND METHOD FOR RAPID AND SENSITIVE DETECTION OF ANTI-PATHOGEN ANTIBODIES
#295MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 NUCLEOCAPSID PHOSPHOPROTEIN AND SANDWICH ELISA METHOD
#296RNA SEPARATION AND RELATED TECHNIQUES FOR DETERMINING VIRUSES SUCH AS CORONAVIRUSES
#297SARS-CoV-2 SPIKE GLYCOPROTEIN-BINDING NUCLEIC ACID MOLECULE, SARS-CoV-2 DETECTION SENSOR, SARS-CoV-2 DETECTION REAGENT, SARS-CoV-2 DETECTION METHOD, AND SARS-CoV-2 VIRUS DEACTIVATOR
#298POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#299BROAD-SPECTRUM PEPTIDE ANTIGEN OF THE NOVEL CORONAVIRUS SARS-COV-2, SPECIFIC NEUTRALIZING ANTIBODY AND USE THEREOF
#300SINGLE-MOLECULE ELECTRONIC MULTIPLEX NANOPORE IMMUNOASSAYS FOR BIOMARKER DETECTION